Yersinia is a gram-positive bacteria that causes terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, northern Europe, and Scandinavia, making these regions the largest markets for Yersinia diagnostics. Furthermore, greater adoption of novel molecular diagnostic tools and higher awareness also contribute to the dominance of these markets. On the other hand, the Asia-Pacific Yersinia diagnostics market holds great potential due to the wide presence of untapped opportunities in emerging Asian countries and the significantly high prevalence of Yersinia infection in Japan.
Treatment of Yersinia infections includes drugs such as aminoglycosides, cephalosporins, tetracyclines, trimethoprim-sulfamethoxazole (TMP-SMZ), and fluoroquinolones. The diagnostic methods used include ELISA, tube agglutination, radioimmunoassay, ultrasonography, stool culture, CT scan, and colonoscopy, among others. Definitive detection of Yersinia enterocolitica isolates can also be performed through the sequencing of the 16S rRNA gene. An immunoblot with plasmodial encoded Yersinia protein also enables serological identification. However, the development of more sensitive, efficient, and yet simple, rapid diagnostic systems that can be applied to direct and indirect diagnosis still remain a challenge in this market.
The global Yersinia diagnostics market is segmented on the following basis:
Test Type
Stool Culture
ELISA
Radioimmunoassay
Tube Agglutination
CT Scan
Ultrasonography
Colonoscopy
Technology
DNA Probes
Immunoassay
Monoclonal Antibodies
PCR
Others
Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Key players identified for the Yersinia diagnostics market include but are not limited to:
Abbott Laboratories, Inc., Hologic, F. Hoffmann-La-Roche, Becton Dickinson, Danaher Corporation, Bio-Rad Laboratories, Affymetrix, Inc., Thermo Fisher Scientific, and others
This report offers the following:
An analysis of several techniques, test types, and regions that would provide a clear understanding of the ongoing and future trends in the global Yersinia diagnostics market
Assessment of market dynamics, such as drivers, restraints, and opportunities prevalent in the market
Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
Company profiles that will highlight key information about the imperative players operating in the global Yersinia diagnostics market
Frequently Asked Questions:
The market for Yersinia Diagnostics Market is expected to reach US$ XX Mn By 2026.
The Yersinia Diagnostics Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.
Abbott Laboratories, Inc., Hologic, F. Hoffmann-La-Roche, Becton Dickinson, Danaher Corporation, Bio-Rad Laboratories, Affymetrix, Inc., Thermo Fisher Scientific are some of the major players in the global market.
